Key result
BNP and NT-proBNP testing are useful for establishing diagnosis and predicting prognosis in heart failure, while the effect of exogenous BNP on clinical outcomes remains unclear.
Population
Patients with heart failure or acute decompensated heart failure
Design
Review
Authors
Loading...
BNP/NT-proBNP testing aids HF diagnosis and prognosis; leaves open exogenous BNP impact on clinical outcomes.
BNP and NT-proBNP are valuable biomarkers for the diagnosis and prognosis of heart failure, and nesiritide improves hemodynamics in acute decompensated heart failure.
Gordon W. Moe (2006) conducted a review in Heart failure. B-type natriuretic peptide (BNP) was evaluated. BNP and NT-proBNP testing are useful for establishing diagnosis and predicting prognosis in heart failure, while the effect of exogenous BNP on clinical outcomes remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: